$53.2 Million is the total value of SVB FINANCIAL GROUP's 21 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Exit | GREENLIGHT BIOSCIENCES HLDS P | $0 | – | -16,950 | -100.0% | -0.01% | – | |
Exit | PARDES BIOSCIENCES INC | $0 | – | -35,923 | -100.0% | -0.12% | – | |
Exit | DICE THERAPEUTICS INC | $0 | – | -21,799 | -100.0% | -1.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
COINBASE GLOBAL INC | 4 | Q3 2023 | 57.5% |
OKTA INC | 4 | Q3 2023 | 20.9% |
ROOT INC | 4 | Q3 2023 | 14.0% |
AXSOME THERAPEUTICS INC | 4 | Q3 2023 | 7.1% |
CAREMAX INC | 4 | Q3 2023 | 3.0% |
PLANET LABS PBC | 4 | Q3 2023 | 2.0% |
MOONLAKE IMMUNOTHERAPEUTICS | 4 | Q3 2023 | 1.7% |
ROVER GROUP INC | 4 | Q3 2023 | 1.2% |
CULLINAN ONCOLOGY INC | 4 | Q3 2023 | 0.8% |
CARIBOU BIOSCIENCES INC | 4 | Q3 2023 | 0.8% |
View SVB FINANCIAL GROUP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ACHIEVE LIFE SCIENCES, INC. | February 10, 2023 | 1,716,764 | 8.8% |
Root, Inc. | February 10, 2023 | 783,012 | 8.6% |
BigCommerce Holdings, Inc. | February 12, 2021 | 392,224 | 0.6% |
ISC8 INC. /DE | February 17, 2015 | 34,533,213 | 11.9% |
View SVB FINANCIAL GROUP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
8-K | 2024-05-07 |
8-K | 2024-05-07 |
8-K | 2024-03-22 |
8-K | 2024-03-20 |
8-K | 2024-02-26 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
8-K | 2024-02-09 |
8-K | 2024-02-01 |
8-K | 2024-01-29 |
View SVB FINANCIAL GROUP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.